Skip to content

Endoscopic clipping prior to EVO vs. EVO in IGV1 bleeding: a multicenter retrospective clinical trial

Endoscopic clipping prior to EVO vs. EVO in IGV1 bleeding: a multicenter retrospective clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017601
Enrollment
Unknown
Registered
2018-08-06
Start date
2015-03-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic treatment of Gastroesophageal varices

Interventions

Group I:Endoscopic clipping prior to EVO
Group II:Traditional EVO

Sponsors

the First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 80 Years

Inclusion criteria

Inclusion criteria: The cirrhosis patients had the history of episodes of upper gastrointestinal bleeding, and presented of isolated gastric varices on endoscopy

Exclusion criteria

Exclusion criteria: 1) Previous history of sclerotherapy, endoscopic band ligation, surgical portosystemic shunt or Interventional therapy; 2) Patients with hepatocellular carcinoma, other malignancy and debilitating diseases.

Design outcomes

Primary

MeasureTime frame
Initial success hemostasis;The dose of cyanoacrylate;Rebleeding rate;Variceal obliteration;Complication rates;

Secondary

MeasureTime frame
The diameter of gastrorenal shunt;

Countries

China

Contacts

Public ContactDerun Kong

the First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026